VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
CDXS
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
CDXSCodexis, Inc.
$1.08$116M
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksCDXSBalance Sheet

Codexis, Inc. (CDXS) Balance Sheet

20Y historyFree accessUpdated daily

Debt of $72.6M against equity of $33.0M produces a debt-to-equity ratio of 2.20 in 2026Q2, up from 0.55 in 2024Q1, with an accumulated deficit of -$627.5M dwarfing the equity base.

Income StatementBalance SheetCash FlowRatios

CDXS Balance Sheet

Annual statement

CDXS Balance Sheet

Codexis, Inc. (CDXS) balance sheet — 20-year assets, liabilities & shareholders' equity history

AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08Dec'07Dec'06
Total Current Assets71.92M96.82M98.77M93.47M162.89M161.89M184.42M114.2M68.2M45.04M27.23M32.84M33.01M35.78M59.77M79.23M92.19M67.38M48.33M93.35M36.64M
Cash & Short-Term Investments54.92M78.21M73.46M65.12M113.98M116.8M150.12M90.5M53.04M31.22M19.24M23.27M26.49M25.14M45.53M53.48M72.4M55.56M37.13M84.07M32.25M
Cash Only27.17M50.79M19.26M65.12M113.98M116.8M149.12M90.5M53.04M31.22M19.24M23.27M26.49M22.13M32M25.76M72.4M31.79M21.9M55.08M32.25M
Short-Term Investments27.75M27.42M54.19M0001M0000003M13.52M27.72M023.78M15.23M29M0
Accounts Receivable7.35M10.73M18.88M19.93M40.87M37.65M29.29M20.16M13.5M11.8M5.92M7.33M3.87M5.41M7.54M18.92M15.33M7.25M6.19M6.43M2.75M
Days Sales Outstanding42.155.64116.15103.7107.65131.19154.8107.4681.3386.144.2763.9940.0161.8931.1955.7452.2531.944.7892.6782.89
Inventory1.6M1.82M1.8M2.69M2.03M1.16M964K371K589K1.04M825K992K1.4M1.49M1.3M4.49M2.82M2.92M2.98M1.64M970K
Days Inventory Outstanding53.0571.0240.3176.5119.4719.0625.68.6617.0426.3930.8854.9852.3537.2915.5139.2136.7563.882.3771.74196.04
Other Current Assets4.72M6.06M4.63M5.74M521K579K638K661K0001.25M02.18M5.39M00-68.04M366K1.56M0
Total Non-Current Assets48.14M50.98M50.24M43.09M87.5M84.5M37.22M34.87M11.09M8.59M8.42M11.81M15.12M23.06M40.2M56.69M49.11M31.65M22.55M20.2M10.02M
Property, Plant & Equipment40.52M43.52M42.9M28.62M61.88M65.46M31.18M30.39M4.76M2.81M2.15M3.11M4M8.45M16.65M24.18M21.45M21.58M16.01M11.1M4.5M
Fixed Asset Turnover1.86x1.62x1.38x2.45x2.24x1.60x2.22x2.25x12.73x17.77x22.66x13.45x8.84x3.78x5.30x5.12x4.99x3.84x3.15x2.28x2.69x
Goodwill2.46M2.46M2.46M2.46M3.24M3.24M3.24M3.24M3.24M3.24M3.24M3.24M3.24M3.24M3.24M3.24M3.24M3.24M3.14M3.1M1.93M
Intangible Assets000000000002.81M6.19M9.56M12.93M16.44M20.16M928K1.79M2.78M2.32M
Long-Term Investments13.77M2.5M2.8M9.7M20.51M14M1.45M0588K671K1.14M1.55M688K795K3.62M10.35M00000
Other Non-Current Assets2.65M2.5M2.08M2.31M1.87M1.79M1.36M1.24M2.5M1.86M1.88M1.1M1M1.02M3.75M2.48M4.26M5.9M1.61M3.21M1.26M
Total Assets120.06M147.8M149.01M136.56M250.39M246.38M221.65M149.07M79.28M53.63M35.65M44.65M48.12M58.84M99.97M135.92M141.3M99.04M70.88M113.54M46.66M
Asset Turnover0.60x0.48x0.40x0.51x0.55x0.43x0.31x0.46x0.76x0.93x1.37x0.94x0.73x0.54x0.88x0.91x0.76x0.84x0.71x0.22x0.26x
Asset Growth %-29.94%-0.81%9.12%-45.46%1.63%11.16%48.68%88.03%47.85%50.43%-20.16%-7.22%-18.22%-41.14%-26.45%-3.81%42.68%39.72%-37.57%143.34%-
Total Current Liabilities23.51M25.32M23.65M35.83M49.07M33.37M24.98M15.39M17.11M24.95M12.37M14.84M13.73M11.2M16.28M28.29M27.48M48.98M42.4M34.18M13.67M
Accounts Payable2.61M1.55M2.84M5.95M3.25M3M2.97M2.62M3.05M3.54M4.23M3.4M4.67M3.96M3.65M10.36M9.21M10M9.17M4.22M2.49M
Days Payables Outstanding62.8660.7463.6169.4631.1549.2278.8961.288.2190.31158.38188.37175.3799.3443.5290.54120.11218.83253.68185.37503.44
Short-Term Debt7.06M0000000000-425K000000000
Deferred Revenue (Current)9.03M7.01M350K10.12M13.73M2.59M1.82M57K3.94M12.29M1.71M6.1M3.5M2M2.19M3.79M4.54M15.4M10.58M5.51M4.33M
Other Current Liabilities011.04M11.41M11.25M11.45M11.12M10.27M5M5.8M4.36M168K1.06M2.62M1.61M6.95M6.79M001.38M1.49M623K
Current Ratio3.06x3.82x4.18x2.61x3.32x4.85x7.38x7.42x3.99x1.81x2.20x2.21x2.40x3.19x3.67x2.80x3.35x1.38x1.14x2.73x2.68x
Quick Ratio2.99x3.75x4.10x2.53x3.28x4.82x7.34x7.40x3.95x1.76x2.13x2.15x2.30x3.06x3.59x2.64x3.25x1.32x1.07x2.68x2.61x
Cash Conversion Cycle32.2965.9292.8610.7595.97101.04101.5254.9210.1522.18-83.23-69.41-83.01-0.153.184.41-31.11-123.13-126.54-20.96-224.51
Total Non-Current Liabilities63.59M71.95M58.44M14.12M56.53M48.62M26.56M28.17M4.86M4.13M4.18M6.93M8.08M6.16M5.24M4.94M6.46M13.22M157.6M166.83M85.75M
Long-Term Debt33.82M40.1M28.91M0000000885K0000000-132.75M00
Capital Lease Obligations113.5M30.16M28.16M12.24M38.28M43.56M22.32M24.95M61K302K00000002.57M8.49M12.9M2.51M
Deferred Tax Liabilities0000000000-885K-1.31M000000132.75M132.75M77.51M
Other Non-Current Liabilities1.35M1.33M1.27M1.23M1.37M1.31M1.27M1.23M1.45M2.32M3.12M3.81M4.26M5.04M3.94M3.46M1.38M1.31M-130.01M2.32M2.58M
Total Liabilities87.1M97.27M82.08M49.95M105.6M81.99M51.54M43.56M21.98M29.08M16.55M21.77M21.81M17.36M21.52M33.23M33.94M62.2M200.01M201.01M99.42M
Total Debt72.59M73.21M59.9M16.02M43.64M47.65M24.95M26.12M303K302K425K425K000007.94M13.35M17.41M4.07M
Net Debt45.41M22.41M40.63M-49.09M-70.35M-69.14M-124.17M-64.38M-52.74M-30.92M-18.82M-22.85M-26.49M-22.13M-32M-25.76M-72.4M-23.84M-8.55M-37.67M-28.17M
Debt / Equity2.20x1.45x0.89x0.19x0.30x0.29x0.15x0.25x0.01x0.01x0.02x0.02x-----0.22x---
Debt / EBITDA-4.66x--------------------
Net Debt / EBITDA-2.92x----------------61.09x----
Interest Coverage-22.72x-8.13x--------------24.16x-6.36x-8.93x-17.94x-14.55x-24.96x
Total Equity32.96M50.53M66.93M86.61M144.8M164.39M170.1M105.52M56.31M24.55M19.1M22.88M26.31M41.48M78.44M102.69M107.36M36.84M-129.12M-87.47M-52.77M
Equity Growth %-125.63%-24.5%-22.73%-40.18%-11.92%-3.36%61.21%87.4%129.38%28.53%-16.52%-13.04%-36.57%-47.12%-23.61%-4.35%191.46%128.53%-47.62%-65.77%-
Book Value per Share0.360.580.911.272.222.552.871.871.080.530.470.580.691.092.132.884.3714.05-47.58-32.23-19.44
Total Shareholders' Equity32.96M50.53M66.93M86.61M144.8M164.39M170.1M105.52M56.31M24.55M19.1M22.88M26.31M41.48M78.44M102.69M107.36M36.84M-129.12M-87.47M-52.77M
Common Stock9K9K8K7K6K6K6K6K5K5K4K4K4K4K4K4K4K3K000
Retained Earnings-627.49M-606.78M-562.81M-497.53M-421.29M-387.7M-366.42M-342.41M-330.47M-315.06M-292.07M-283.51M-275.93M-256.86M-215.56M-184.7M-168.15M-159.61M-139.32M-94.19M-55.22M
Treasury Stock000000000000000000000
Accumulated OCI-13K8K52K000000-472K0405K-142K-32K-136K-407K-34K-252K139K537K-52K
Minority Interest000000000000000000000

Key Metrics

Growth RegimeContracting
ProfitabilityNegative
Balance SheetStrained
Cash FlowBurning
Top Statement Risk

Shrinking equity against persistent losses

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q2)

Equity Erosion Outpaces Debt Reduction

According to reported figures, Codexis's stockholders' equity fell from $79.3M in 2024Q1 to $33.0M in 2026Q2, a decline of roughly 58%, while total debt stayed largely near $70M, pushing the balance sheet toward greater strain.

The shrinking equity base appears to reflect sustained operating losses, with retained earnings deficits deepening from -$509.0M to -$627.5M over the period. Total debt has been broadly stable rather than retired, so the deterioration is driven by the equity side of the ledger rather than new borrowing. Investors should monitor whether the company can rebuild capital through profitability or will need external funding, which may warrant further investigation.

Leverage Rising as Equity Shrinks

Based on Codexis's reported figures, the debt-to-equity ratio climbed from 0.55 in 2024Q1 to 2.20 in 2026Q2, with total debt of $72.6M now representing a far larger claim against a much thinner equity cushion.

The rise in leverage appears to be a function of equity compression rather than debt accumulation, since total debt has remained in a $41M to $73M band. A D/E above 2.0 suggests limited capacity to absorb further losses before equity becomes more fragile. Refinancing terms and debt maturity schedules are not provided in the data, so refinancing risk cannot be assessed and warrants further investigation.

Cash Buffer Thins Against Ongoing Burn

As reported in financial statements, Codexis held $27.2M in cash in 2026Q2 against a current ratio of 3.06, with cash having fallen from a $58.0M peak in 2024Q1 amid persistent negative free cash flow.

The current ratio remains above 3.0, which on its face suggests adequate near-term coverage of current obligations. However, cash has declined by more than half since early 2024 while free cash flow has remained negative in most quarters. The current ratio may overstate liquidity if a meaningful portion of current assets is not readily convertible, so investors should monitor cash runway closely.

Accumulated Deficit Dominates Equity Structure

Based on Codexis's reported figures, the accumulated deficit of -$627.5M in 2026Q2 dwarfs the $33.0M equity balance, indicating that paid-in capital has been largely consumed by cumulative losses over the ten-quarter window.

The scale of the deficit relative to equity suggests that reported book value depends heavily on continued capital contributions to offset losses. Stock-based compensation and share dilution noted in prior income statement findings may further pressure per-share equity over time. The data does not show repurchase activity, so the equity trend is best read as a function of losses and dilution rather than capital return.

Asset Base Light Against Fixed Plant

According to reported financials, PPE net declined from $27.0M in 2024Q1 to $40.5M in 2026Q2 after a dip, while goodwill remained fixed at $2.5M, indicating a modestly asset-light structure with limited acquisition-driven intangibles risk.

Goodwill of $2.5M is immaterial relative to total assets of $120.1M, so impairment risk appears low. PPE has moved in both directions over the period, with a notable step-up from 2024Q3 to 2025Q1 that may reflect capacity investment, though the data does not confirm its purpose. The asset mix suggests the business relies more on operating capability than on capital-heavy infrastructure, consistent with the modest CapEx levels noted in prior cash flow findings.

Accumulated Deficit May Mask Recovery Signals

Based on Codexis's reported figures, the deficit-driven equity decline may overstate balance sheet fragility, since the 2026Q2 current ratio of 3.06 and modest goodwill suggest near-term obligations are covered even as book equity contracts.

A large accumulated deficit relative to paid-in capital can make book equity appear weaker than the underlying operating position, particularly if future revenue spikes similar to 2025Q4 recur. Conversely, the current ratio and low goodwill may be concealing the fact that cash has been drawn down substantially, so a reversal in working capital timing could quickly erode the apparent liquidity cushion. Investors should weigh whether the headline equity figure or the liquidity metrics better reflect the company's real capacity to fund operations.

CDXS — Frequently Asked Questions

Quick answers to the most common questions about buying CDXS stock.

What are the total assets of Codexis, Inc. (CDXS)?

As of 2025, Codexis, Inc. (CDXS) had total assets of $147.8M including $96.8M in current assets.

How much debt does Codexis, Inc. (CDXS) have?

Codexis, Inc. (CDXS) carries total debt of $73.2M, offset by $78.2M in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.

What is the book value or shareholders' equity of Codexis, Inc.?

Codexis, Inc. (CDXS) has total shareholders' equity (book value) of $50.5M ($0.58 book value per share). Book value represents the net worth of the company belonging to common stock holders.

What is Codexis, Inc.'s current ratio and liquidity?

Codexis, Inc. (CDXS) reported a current ratio of 3.82x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.